CN Patent

CN118974018A — 达罗他胺的晶型

Assigned to Quimikaxin Tetika Co ltd · Expires 2024-11-15 · 2y expired

What this patent protects

本发明涉及达罗他胺的晶型及其制备方法。此外，本发明还涉及所述晶型在制备用于治疗前列腺癌的药物组合物中的用途。

USPTO Abstract

本发明涉及达罗他胺的晶型及其制备方法。此外，本发明还涉及所述晶型在制备用于治疗前列腺癌的药物组合物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN118974018A
Jurisdiction
CN
Classification
—
Expires
2024-11-15
Drug substance claim
No
Drug product claim
No
Assignee
Quimikaxin Tetika Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.